IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$682.78 USD
+147.24 (27.49%)
Updated Aug 4, 2025 03:59 PM ET
After-Market: $682.70 -0.08 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/30/2025
Time: BMO |
9/2025 | $3.09 | 1.15% |
Earnings Summary
For their last quarter, IDEXX Laboratories (IDXX) reported earnings of $3.63 per share, beating the Zacks Consensus Estimate of $3.31 per share. This reflects a positive earnings surprise of 9.67%. Look out for IDXX's next earnings release expected on October 30, 2025. For the next earning release, we expect the company to report earnings of $3.09 per share, reflecting a year-over-year increase of 35.66%.
Earnings History
Price & Consensus
Zacks News for IDXX
Idexx (IDXX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
Idexx (IDXX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
IDXX FAQs
IDEXX Laboratories, Inc. (IDXX) has announced they will report their next quarter earnings on October 30, 2025. For the next earning release, we expect the company to report earnings of $3.31 per share, reflecting a year-over-year increase of 35.66%.
IDEXX Laboratories, Inc. has announced they will report their previous quarter earnings after the close of the market on October 30, 2025.
The Zacks Consensus Estimate for IDEXX Laboratories, Inc. (IDXX) for the quarter ending in June 2025 is $3.31 a share. We expect IDEXX Laboratories, Inc. to miss by 1.15%.
In the earnings report for the quarter ending in September 2024, IDEXX Laboratories, Inc. (IDXX) announced earnings of $2.80 per share versus the Zacks Consensus Estimate of $2.69 per share, representing a surprise of 4.09%.